TransMed7, LLC Announces First Revenue from Concorde Family of Devices
Portola Valley, CA, September 6, 2023 – TransMed7, LLC announced today the first sales of Concorde (Single Insertion / Multiple Collection (SIMC®)
News & Announcements
TransMed7, LLC Announces First Clinical Use of VacuPac®, a New Self-Contained, Vacuum-Assist Attachment for all of its Vacuum-Assisted, Single Insertion – Multiple Collection (SIMC®) Platforms of Biopsy Devices
Portola Valley, CA, March 21, 2023 – TransMed7, LLC announced today the first clinical use of VacuPac®, a new self-contained external vacuum-assist
TransMed7, LLC Announces First Clinical Cases of Concorde Soft Tissue Biopsy Devices for Commercial Launch
Portola Valley, CA, February 6, 2023 – TransMed7, LLC announced today that the “First in Human” series of clinical cases using commercial
TransMed7, LLC Announces First Clinical Use of Heron Soft Tissue Biopsy Devices for Commercial Launch
Portola Valley, CA, August 16, 2022 – TransMed7, LLC announced today that the “First in Human” clinical case of the commercial production
TransMed7, LLC Announces First Clinical Use of SpeedBird™ Breast Biopsy Devices for Commercial Launch
Portola Valley, CA, August 8, 2022 – TransMed7, LLC announced today that the first clinical cases of the final commercial production version
TransMed7, LLC Announces First Results from Clinical Use of its Vacuum-Assisted, Single Insertion – Multiple Collection (SIMC™) Platform of Breast Biopsy Devices
PHOENIX, AZ, September 22, 2020 – TransMed7, LLC announced today that the first of the vacuum-assisted, Single Insertion – Multiple Collection (SIMC™)
TransMed7, LLC Announces 510(k) Clearance by the U.S. FDA for its Concorde US
(Ultrasound) and Concorde ST (Stereotactic) Soft Tissue Biopsy Device Platform
Portola Valley, CA –TransMed7, LLC announced today that the United States Food and Drug Administration (FDA) has cleared its 510(k) application for the company to market TransMed7’s new Concorde USTM and Concorde STTM soft tissue biopsy devices.
Pre-Production Test Devices of Heron’s “Zero5” Work Element Scaled to 18 Gauge and on Long (16 cm+) Needles Being Prepared
TransMed7 is delighted to announce the ongoing production of prototype HeronTM devices for its newly announced Project Company, Heron MD, LLC. Annually
TransMed7 Continues to Strengthen its Intellectual Property Position
TransMed7’s Intellectual Property portfolio is built on a robust patent generation and protection strategy, developed and backed by deep expertise with our
Prototypes for Cardinal, a Fine Needle Core Biopsy Device and VacuPac, a Portable External Vacuum Assist Device Shown at ASBrS
We were delighted to present several prototype CardinalTM devices for the first time at this year’s ASBrS meeting. As expected, there was